Advances in targeting insulin-like growth factor signaling pathway in cancer treatment.
about
Expression of IMP3 as a marker for predicting poor outcome in gastroenteropancreatic neuroendocrine neoplasms.Cathepsin Inhibition Prevents Autophagic Protein Turnover and Downregulates Insulin Growth Factor-1 Receptor-Mediated Signaling in NeuroblastomaExpression and clinical significance of insulin-like growth factor 1 in lung cancer tissues and perioperative circulation from patients with non-small-cell lung cancer.Cardio-oncology Related to Heart Failure: Common Risk Factors Between Cancer and Cardiovascular Disease.The post-translational modification, SUMOylation, and cancer (Review).
P2860
Advances in targeting insulin-like growth factor signaling pathway in cancer treatment.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Advances in targeting insulin-like growth factor signaling pathway in cancer treatment.
@en
type
label
Advances in targeting insulin-like growth factor signaling pathway in cancer treatment.
@en
prefLabel
Advances in targeting insulin-like growth factor signaling pathway in cancer treatment.
@en
P2093
P1476
Advances in targeting insulin-like growth factor signaling pathway in cancer treatment.
@en
P2093
Changyu Liu
Hexiao Tang
Liangkun You
Shengling Fu
Yongde Liao
P304
P356
10.2174/13816128113199990595
P577
2014-01-01T00:00:00Z